Inhaled bronchodilators in cystic fibrosis: a Cochrane review

C. P. Halfhide, J. M. Couriel (Liverpool, United Kingdom)

Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Session: Cystic fibrosis lung disease: molecules images and drugs
Session type: Oral Presentation
Number: 1977
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. P. Halfhide, J. M. Couriel (Liverpool, United Kingdom). Inhaled bronchodilators in cystic fibrosis: a Cochrane review. Eur Respir J 2006; 28: Suppl. 50, 1977

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
Source: Eur Respir J 2014; 44: 382-393
Year: 2014



Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Inhaled steroids in children with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004

Long-term tiotropium bromide therapy was retrospectively analyzed in adults with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015

Inhaled antibiotics in cystic fibrosis: what we should do and what we still do not know
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016


Inhalation therapy in cystic fibrosis
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016



Inhaled mannitol as treatment for children with cystic fibrosis
Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease
Year: 2008


Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis
Source: Eur Respir J 2011; 37: 1091-1095
Year: 2011



Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014


Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation
Source: Eur Respir J 2015; 45: 541-544
Year: 2015


Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Inhaled mannitol in cystic fibrosis: clinical experience in Verona CF centre
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020